Follow-up study of wiedemann-rautenstrauch syndrome : Long-term survival and comparison with rautenstrauch's patient GARBOLEDA, Humberto; ARBOLEDA, Gonzalo.Birth defects research. Clinical and molecular teratology. 2005, Vol 73, Num 8, pp 562-568, issn 1542-0752, 7 p.Article

Inhibition of caspases but not of calpains temporarily protect against C2-ceramide-induced death of CAD cellsARBOLEDA, Gonzalo; WATERS, Catherine; GIBSON, Rosemary et al.Neuroscience letters. 2007, Vol 421, Num 3, pp 245-249, issn 0304-3940, 5 p.Article

Regulation of ceramide-induced neuronal death : Cell metabolism meets neurodegenerationARBOLEDA, Gonzalo; MORALES, Luis Carlos; BENITEZ, Bruno et al.Brain research reviews. 2009, Vol 59, Num 2, pp 333-346, issn 0165-0173, 14 p.Article

Neonatal Progeroid Syndrome (Wiedemann-Rautenstrauch Syndrome): Report of Three Affected SibsARBOLEDA, Gonzalo; MORALES, Luis Carlos; OUINTERO, Luis et al.American journal of medical genetics. Part A. 2011, Vol 155, Num 7, pp 1712-1715, issn 1552-4825, 4 p.Article

Differential regulation of AKT, MAPK and GSK3β during C₂-ceramide-induced neuronal deathARBOLEDA, Gonzalo; CARDENAS, Yolanda; RODRIGUEZ, Yeldy et al.Neurotoxicology (Park Forest South). 2010, Vol 31, Num 6, pp 687-693, issn 0161-813X, 7 p.Article

Angiotensin-converting enzyme and alpha-2-macroglobulin gene polymorphisms are not associated with Alzheimer's disease in Colombian patientsCAMELO, Dalila; ARBOLEDA, Gonzalo; YUNIS, Juan J et al.Journal of the neurological sciences. 2004, Vol 218, Num 1-2, pp 47-51, issn 0022-510X, 5 p.Article

Haplogroup analysis of the risk associated with APOE promoter polymorphisms (-219T/G, -491A/T and -427T/C) in Colombian Alzheimer's disease patientsPARRA-BONILLA, Glenda; ARBOLEDA, Gonzalo; YUNIS, Juan et al.Neuroscience letters. 2003, Vol 349, Num 3, pp 159-162, issn 0304-3940, 4 p.Article